Latest news with #CBOECA
Cision Canada
5 days ago
- Business
- Cision Canada
BTQ Technologies Corp. Execution of Definitive Agreements for C$40 Million Previously Announced Offering
VANCOUVER, BC, /CNW/ - BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, is pleased to announce that its previously disclosed C$40 million financing (the "Offering") is fully subscribed, with definitive agreements executed by all participating investors. To accommodate strong investor demand and streamline the regulatory process, the Offering is now being conducted pursuant to a prospectus supplement to the Company's final short form base shelf prospectus dated April 29, 2025, which is to be filed in accordance with applicable Canadian securities laws and available under the Company's SEDAR+ profile at Issuance of the Shares is subject to a number of conditions, including receipt of customary CBOE Canada approvals and is expected to be completed in the near term. An update will be provided upon formal closing. As previously announced, BTQ intends to use the net proceeds from the Offering to support general corporate purposes, working capital needs, acceleration of product development across both hardware and software, and potential strategic acquisitions. This press release shall not constitute an offer to sell or the solicitation of an offer to buy Shares in the United States, nor shall there be any sale of the Shares in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or under any securities laws of any State of the United States, and may not be offered or sold in the United States or to, or for the account or benefit of, a "U.S. person" (as defined in Regulation S under the U.S. Securities Act) absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and all applicable state securities laws. About BTQ BTQ Technologies Corp. (Cboe CA: BTQ | FSE: NG3 | OTCQX: BTQQF) is a vertically integrated quantum company accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio, BTQ pioneered the industry's first commercially significant quantum advantage and now delivers a full-stack, neutral-atom quantum computing platform with end-to-end hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense. ON BEHALF OF THE BOARD OF DIRECTORS Olivier Roussy Newton CEO, Chairman Neither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. Forward Looking Information Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the intended closing of the Offering and use of net proceeds in relation thereto, business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information. The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive. Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
Malaysian Reserve
7 days ago
- Business
- Malaysian Reserve
BTQ Technologies Corp. Announces Brokered LIFE Financing of C$40 Million
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC and SEOUL, Korea, July 8, 2025 /CNW/ – BTQ Technologies Corp. (the 'Company') (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks is pleased to announce a best efforts private placement, of 5,555,555 common shares of the Company ('Common Shares') at a price of C$7.20 per Common Share, for aggregate gross proceeds of C$40,000,000 (the 'Offering'). A.G.P. Canada Investments ULC ('Agent') is acting as the sole bookrunner and agent for the Offering and A.G.P./Alliance Global Partners is acting as sole U.S. placement agent for the Offering. The Company plans to use the net proceeds for general corporate purposes, working capital and to accelerate the development of both hardware and software products and potential acquisitions. The Offering is scheduled to close on or about July 10, 2025 ('Closing Date'), and is subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including of Cboe Canada Inc. The Company has agreed to pay the Agent a cash fee equal to 7% of the gross proceeds from the Offering. In addition, upon closing of the Offering, the Company has agreed to issue the Agent non-transferable broker warrants (each, a 'Broker Warrant') equal to 2.5% of the total number of Common Shares sold pursuant to the Offering. Each Broker Warrant will be exercisable for one Common Share at a price of C$12.60 per Broker Warrant and is exercisable for a period of 60 months following the completion of the Offering. The Common Shares to be issued under the Offering will be offered to purchasers pursuant to the listed issuer financing exemption ('LIFE Exemption') under Part 5A of National Instrument 45-106 – Prospectus Exemptions ('NI 45-106'), in the provinces of British Columbia, Alberta and Ontario. The Common Shares offered under the LIFE Exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws. The Common Shares may also be offered to persons in the United States or to, or for the account or benefit of, 'U.S. persons' (as defined in Regulation S under the United States Securities Act of 1933, as amended (the 'U.S. Securities Act')) pursuant to exemptions from the registration requirements under the and all applicable U.S. state securities laws, as well as outside Canada and the United States on a basis which does not require the qualification or registration of any of the Company's securities or require the Company to be subject to any ongoing disclosure requirements under any domestic securities laws. There is an offering document related to the LIFE Exemption portion of the Offering that can be accessed under the Company's profile on SEDAR+ at and on the Company's website at Prospective investors should read this offering document before making an investment decision. The securities to be offered pursuant to the Offering have not been, and will not be, registered under the U.S. Securities Act or under any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, a 'U.S. person' absent registration or any applicable exemption from the registration requirements under the U.S. Securities Act and applicable U.S. state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About BTQ BTQ Technologies Corp. (Cboe CA: BTQ | FSE: NG3 | OTCQX: BTQQF) is a vertically integrated quantum company accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio, BTQ pioneered the industry's first commercially significant quantum advantage and now delivers a full-stack, neutral-atom quantum computing platform with end-to-end hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense. Forward-Looking Statements: Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the timing of the closing of the Offering, the use of proceeds from the Offering, business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares and its use of proceeds from the Offering. Forward-looking statements or information often can be identified by the use of words such as 'anticipate', 'intend', 'expect', 'plan' or 'may' and the variations of these words are intended to identify forward-looking statements and information. The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive. Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. The CBOE Canada does not accept responsibility for the adequacy or accuracy of the content of this Press Release.
Cision Canada
7 days ago
- Business
- Cision Canada
BTQ Technologies Corp. Announces Brokered LIFE Financing of C$40 Million
, July 8, 2025 /CNW/ - BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks is pleased to announce a best efforts private placement, of 5,555,555 common shares of the Company ("Common Shares") at a price of C$7.20 per Common Share, for aggregate gross proceeds of C$40,000,000 (the "Offering"). A.G.P. Canada Investments ULC ("Agent") is acting as the sole bookrunner and agent for the Offering and A.G.P./Alliance Global Partners is acting as sole U.S. placement agent for the Offering. The Company plans to use the net proceeds for general corporate purposes, working capital and to accelerate the development of both hardware and software products and potential acquisitions. The Offering is scheduled to close on or about July 10, 2025 ("Closing Date"), and is subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including of Cboe Canada Inc. The Company has agreed to pay the Agent a cash fee equal to 7% of the gross proceeds from the Offering. In addition, upon closing of the Offering, the Company has agreed to issue the Agent non-transferable broker warrants (each, a "Broker Warrant") equal to 2.5% of the total number of Common Shares sold pursuant to the Offering. Each Broker Warrant will be exercisable for one Common Share at a price of C$12.60 per Broker Warrant and is exercisable for a period of 60 months following the completion of the Offering. The Common Shares to be issued under the Offering will be offered to purchasers pursuant to the listed issuer financing exemption ("LIFE Exemption") under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), in the provinces of British Columbia, Alberta and Ontario. The Common Shares offered under the LIFE Exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws. The Common Shares may also be offered to persons in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) pursuant to exemptions from the registration requirements under the and all applicable U.S. state securities laws, as well as outside Canada and the United States on a basis which does not require the qualification or registration of any of the Company's securities or require the Company to be subject to any ongoing disclosure requirements under any domestic securities laws. There is an offering document related to the LIFE Exemption portion of the Offering that can be accessed under the Company's profile on SEDAR+ at and on the Company's website at Prospective investors should read this offering document before making an investment decision. The securities to be offered pursuant to the Offering have not been, and will not be, registered under the U.S. Securities Act or under any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, a "U.S. person" absent registration or any applicable exemption from the registration requirements under the U.S. Securities Act and applicable U.S. state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About BTQ BTQ Technologies Corp. (Cboe CA: BTQ | FSE: NG3 | OTCQX: BTQQF) is a vertically integrated quantum company accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio, BTQ pioneered the industry's first commercially significant quantum advantage and now delivers a full-stack, neutral-atom quantum computing platform with end-to-end hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense. Forward-Looking Statements: Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the timing of the closing of the Offering, the use of proceeds from the Offering, business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares and its use of proceeds from the Offering. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information. The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive. Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
Cision Canada
08-07-2025
- Business
- Cision Canada
BTQ Launches World's First Quantum Proof-of-Work Simulator, Delivering the First Commercial Demonstration of Quantum Advantage in Blockchain Consensus
BTQ Quantum Proof-of-Work (QPoW) Simulator offers a live, interactive platform to demonstrate quantum-native consensus mechanisms that remain compatible with existing blockchain infrastructure. QPoW delivers measurable quantum advantage while eliminating vulnerabilities to quantum attacks, offering energy-efficient, post-quantum secure alternatives to legacy proof-of-work systems. The release follows BTQ's leadership role in global standards development, with QPoW adopted as the first consensus work-item by Quantum Industrial Standard Association (QuINSA) and positioned to help future-proof digital assets, CBDCs, and high-value payment networks. VANCOUVER, BC, July 8, 2025 /CNW/ - BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, today unveiled its Quantum Proof-of-Work Simulator, the first publicly accessible platform that showcases a fully quantum-native mining algorithm that remains verifiable on classical hardware. The release marks a milestone in securing digital assets, offering a quantum analogue to Bitcoin's SHA-256 proof-of-work and creating a path to future-proof digital assets against emerging quantum threats. This achievement follows the QuINSA standards organization adopting QPoW as the first consensus work-item in its baseline specification and appointing BTQ to chair of the alliance's quantum communications working group, positioning QPoW as a leading contender for the forthcoming ISO-style standards for quantum-secure blockchain technologies. "Quantum Proof-of-Work shows that quantum hardware can secure, not threaten, the next generation of digital money," said Olivier Roussy Newton, CEO of BTQ Technologies. "Our simulator offers researchers, developers, and miners a first-hand look at how quantum machines can reinforce consensus while preserving compatibility with today's classical infrastructure." "This advancement further solidifies our continued commitment to delivering a demonstrable, practical quantum advantage to the market," added Roussy Newton. "For the first time, the digital-asset ecosystem can interact with a quantum-secure, energy-efficient consensus mechanism—one that aligns with global regulatory momentum and keeps critical infrastructure resilient in the quantum era." Key Highlights Live, real-time mining cycles demonstrate measurable quantum advantage using coarse-grained boson sampling. Adjustable parameters —photon count, optical modes, measurement bins—let users explore security-performance trade-offs. Interactive analytics compare miner outputs, visualize network statistics, and validate submissions through total-variation-distance (TVD) and peak-bin-percentage (PBP) checks. Energy-efficient design decouples difficulty from power consumption, relying on photonic hardware quality rather than brute-force hashing. Post-quantum resilience eliminates vulnerabilities to Grover-style attacks by shifting the work function from hash inversion to provably hard quantum sampling. Implications for Digital Assets Current proof-of-work systems face two converging pressures; escalating energy demands from ASIC mining and looming quantum attacks capable of quadratic speed-ups. BTQ's QPoW replaces the hash puzzle with a boson sampling task that runs on today's small photonic quantum devices. Network operators can raise or lower the difficulty by changing the photon count and optical modes, which improves security against quantum adversaries without driving up power consumption. As the difficulty of the boson sampling problem increases, quantum devices will gain a larger advantage in creating valid samples, but since the task is quantum in nature, no single quantum device will have an outsized advantage in producing blocks over other quantum devices. QPoW therefore gives digital-asset networks a simple and practical way to stay efficient and secure in the quantum era. Regulatory Urgency Policy makers are moving in lock-step toward mandatory quantum resilience. The European Commission's Coordinated Implementation Roadmap for the Transition to Post-Quantum Cryptography, issued on 23 June 2025, directs all EU Member States to begin PQC migration by 2026 and to secure critical infrastructure by 2030. In the United States, NIST's March 2025 selection of the HQC algorithm as a fifth post-quantum standard signalled the transition from guidance to implementation. Together these milestones underscore the need for consensus layers, such as BTQ's QPoW, whose security assumptions remain intact in a quantum era. Central-Bank Perspective The systemic importance of quantum-secure settlement was highlighted at the Bank for International Settlements' Quantum-Readiness for Central Banks and Supervisors conference earlier this year, where 39 central banks agreed that next-generation ledgers must be robust against quantum attacks. QPoW's classically verifiable yet quantum-native design aligns with the BIS mandate and offers a practical path for wholesale CBDC pilots and other high-value payment rails to achieve quantum-readiness without replacing existing node infrastructure. Ecosystem Momentum QPoW is part of BTQ's wider execution roadmap. Last month, BTQ unveiled the Quantum Stablecoin Settlement Network (QSSN) to extend quantum security to tokenised dollars and entered a strategic partnership with QPerfect to validate QPoW on neutral-atom quantum processors. These milestones advance BTQ's core mission of bringing practical quantum advantage to market through a full-stack platform. These initiatives position the company to accelerate the commercial adoption of quantum-secure finance and other quantum-grade quantum solutions. The QPoW simulator is live today at About BTQ BTQ Technologies Corp. (Cboe CA: BTQ | FSE: NG3 | OTCQX: BTQQF) is a vertically integrated quantum company accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio, BTQ pioneered the industry's first commercially significant quantum advantage and now delivers a full-stack, neutral-atom quantum computing platform with end-to-end hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense. Connect with BTQ: Website | LinkedIn | X/Twitter ON BEHALF OF THE BOARD OF DIRECTORS Olivier Roussy Newton CEO, Chairman Neither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. Forward Looking Information Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information. The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive. Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
The Market Online
02-07-2025
- Business
- The Market Online
Onco-Innovations reveals new study on global applicability of lung cancer clinical trials
Onco-Innovations (CBOE CA:ONCO) stated that the co-founders of its wholly-owned subsidiary, Inka Health Corp., have authored an intriguing new study The study addresses a critical challenge in oncology research: how to ensure that clinical trial results are relevant and applicable to the diverse patient populations encountered in everyday clinical practice across different countries and healthcare systems Using advanced modeling techniques, the study demonstrated that trial outcomes could be translated to real-world settings with pinpoint accuracy—within less than one percent error over a 30-month period Onco-Innovations (CBOE CA:ONCO) last traded at C$2.23 This content has been prepared in collaboration with Onco-Innovations Ltd. , a third-party issuer, and is intended for informational purposes only. Onco-Innovations (CBOE CA:ONCO) stated that the co-founders of its wholly-owned subsidiary, Inka Health Corp., have authored an intriguing new study titled Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations: A Case Study using Lung-MAP S1400I , published in medRxiv in June 2025. The study addresses a critical challenge in oncology research: how to ensure that clinical trial results are relevant and applicable to the diverse patient populations encountered in everyday clinical practice across different countries and healthcare systems. Using advanced modeling techniques, the study demonstrated that trial outcomes could be translated to real-world settings with pinpoint accuracy—within less than one percent error over a 30-month period. Implications for global drug development The findings have significant implications for the future of clinical trial design and drug development. By simulating patient outcomes in advance, researchers can optimize trial parameters and better define target populations, reducing risk and accelerating development timelines. These methodologies are foundational to SynoGraph, Inka Health's next-generation causal AI platform, which aims to revolutionize drug development through globally applicable, real-world analytics. Study highlights The research focused on the Lung-MAP S1400I trial, a leading randomized study for advanced non-small cell lung cancer (NSCLC). It evaluated whether trial results could accurately predict outcomes for real-world patients in the U.S., Germany, and France—many of whom would not have qualified for the original trial due to age, comorbidities, or other factors. Key findings include: Enhanced predictive accuracy : By incorporating external clinical knowledge, the model achieved an average discrepancy of just 0.27 months (8.2 days) between predicted and actual survival outcomes. : By incorporating external clinical knowledge, the model achieved an average discrepancy of just 0.27 months (8.2 days) between predicted and actual survival outcomes. Broader applicability : The approach significantly improved the alignment of trial results with real-world outcomes, offering a scalable solution for global oncology research. : The approach significantly improved the alignment of trial results with real-world outcomes, offering a scalable solution for global oncology research. Regulatory relevance: The study supports growing demands from regulators, payers, and clinicians for evidence that reflects real-world patient experiences. Leadership insights Among the study's co-authors is Dr. Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute. A globally recognized leader in oncology, Dr. Subbiah has led over 100 early-phase clinical trials and contributed to multiple FDA and EMA approvals, including tissue-agnostic therapies targeting BRAF and RET genetic alterations. He has authored more than 400 peer-reviewed publications in top-tier journals such as The New England Journal of Medicine , Nature Medicine , and JAMA Oncology . 'The ability to model outcomes for patient groups who wouldn't typically be included in clinical trials is not just a technical achievement-it's a clinical and strategic one,' he said in a news release. 'It opens the door to faster trial design, smarter expansion decisions, and better evidence for patients who are often overlooked. These kinds of tools will be essential as we push toward more globally inclusive and data-driven drug development.' Onco-Innovations Ltd. studies cancer research and treatment, specializing in oncology. Onco-Innovations (CBOE CA:ONCO) last traded at C$2.23. Join the discussion: Find out what everybody's saying about this stock on the Onco-Innovations Bullboard, and check out the rest of Stockhouse's stock forums and message boards. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.
